03.01.12 Units and systems for clinical chemical determination
Units and systems for clinical chemical determination
Oct 31, 2016
DiaSys Celebrates 25th Anniversary with Essential Product Launches
The worldwide rapid rise in diabetes is a challenge for treatment as well as for diagnosis and monitoring. With the new test HbA1c net FS, DiaSys has introduced an innovative product with highest accuracy setting new standards for reliable results in diagnosing and monitoring diabetes. Based on enzymatic measurement Hba1c net FS ensures highest specificity without interferences by hemoglobin variants or other substances in blood as well as outstanding precision. In combination with the DiaSys analyzers, JCA-BioMajesty® BM 6010/C and respons®910, labs of every size can optimize their workflow for HbA1c due to the fully automated process including on-board hemolysis.
Besides this crucial product launch, other major achievements were made in time for DiaSys’ 25th anniversary. Under the trademark QDx DiaSys announced a point-of-care product line comprising test strips and devices for various diagnostic fields as cardiac, vitamin D, allergy, anemia, lipids and urinalysis. The recently founded subsidiary DiaSys USA introduced the respons®910VET as versatile solution for the veterinarian lab. Furthermore, respons®910UP was presented. The upgraded version of DiaSys’ analyzer for the small clinical lab offers improved handling and performance and lead to boosting sales establishing DiaSys as player in the systems market.
25 years of success as a mid-size company in the challenging and ever changing market of in-vitro diagnostics - DiaSys takes this opportunity to thank all employees, customers and partners for their contribution and confidence and looks forward to a common prospering future.
DiaSys Diagnostic Systems is a leading specialist in development and manufacturing of diagnostic system solutions of high quality combined with ease of use and reduced environmental burden. Focusing on clinical chemistry and immunoturbidimetric tests, DiaSys has introduced more than 90 optimized reagents in user-friendly kits for manual or automated use. The products give reliable results in routine and special diagnostics as e.g. in diabetes, metabolic syndrome, lipid disorders, iron metabolism, pancreatic, kidney or liver diseases.
The analytical instrumentation portfolio comprises automated clinical chemistry system analyzers for small to mid-size labs (respons®, BioMajesty®JCA-BM 6010/C), semi-automated analyzers, POCT instruments (InnovaStar®) as well as glucose/lactate analyzers (SensoStar®). Additionally, DiaSys offers a broad range of quality control material (TruLab®).
DiaSys is an ISO certified company since 1996 (ISO 13485:2003, ISO 9001:2000). To date, customers and partners in more than 100 countries around the world rely on DiaSys quality.